| Financial Year |
March 31 2023 |
| Monetary Funds |
446,849,681.86 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
286,899,308.06 |
| Advances to Suppliers |
29,421,540.67 |
| Other Receivables |
2,982,419.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
361,531,775.57 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
29,190,036.10 |
| Total Current Assets |
1,183,068,016.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
76,513,768.74 |
| Investment Properties |
-- |
| Fixed Assetes |
820,173,055.06 |
| Under-construction Projects |
471,676,882.03 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
168,212,924.23 |
| R&D expenses |
-- |
| Goodwill |
360,988,990.55 |
| Long-Term Deferred and Prepaid Expenses |
4,209,910.69 |
| Deferred Income Tax Assets |
6,759,360.43 |
| Other Non-Current Assets |
27,837,588.99 |
| Sub-Total of Non-Current Assets |
1,953,372,480.72 |
| Total Assets |
3,136,440,497.06 |
| Short-Term Loans |
467,943,672.72 |
| Trading Financial liabilities |
-- |
| Notes Payable |
84,335,454.06 |
| Accounts Payable |
191,761,052.04 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,661,100.19 |
| Taxes Payable |
5,811,732.34 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
40,770,042.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
365,521.33 |
| Other Current Liabilities |
548,913.69 |
| Sub-Total of Current Liabilities |
805,419,902.20 |
| Long-term Loans |
275,360,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
36,485,418.30 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
344,035,510.43 |
| Total Liabilities |
1,149,455,412.63 |
| Paid-In Capital(Or Share Stock) |
327,957,575.00 |
| Capital Surplus |
934,027,787.44 |
| Surplus Reserve |
63,996,082.73 |
| LESS:Treasury Stock |
29,179,860.00 |
| Undistributed Profits |
464,873,737.11 |
| Minority Stockholder's Interest |
225,309,762.15 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,761,675,322.28 |
| Owner's Equity（Stockholder's Equity） |
1,986,985,084.43 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,136,440,497.06 |
